SCHEMBL2641374

SCHEMBL2641374

COc1cccc(OC[C]=O)c1OC

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.50
NFE2L2 Q16236 2/20 0.41
MAPK1 P28482 1/20 0.41
ABCB1 P08183 3/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 1/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA14 Q9ULX7 2/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
PRMT1 Q99873 1/20 0.38
CA4 P22748 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11512639 0.89 SMN1; SMN2 (0.59) SMN1; SMN2NFE2L2MAPK1ALDH1A1TSHR
SCHEMBL514580 0.82 CA12 (0.54) SMN1; SMN2ALDH1A1L3MBTL1POLBCA12
SCHEMBL4090880 0.81 SMN1; SMN2 (0.50) SMN1; SMN2MAPK1ABCB1TSHRL3MBTL1
SCHEMBL5722457 0.81 SMN1; SMN2 (0.50) SMN1; SMN2NFE2L2MAPK1ABCB1ALDH1A1
SCHEMBL5306203 0.80 SMN1; SMN2 (0.53) SMN1; SMN2MAPK1ALDH1A1TSHRL3MBTL1
SCHEMBL2096486 0.79 SMN1; SMN2 (0.55) SMN1; SMN2NFE2L2MAPK1ABCB1ALDH1A1
SCHEMBL25434306 0.77 CA1 (0.61) SMN1; SMN2NFE2L2MAPK1ALDH1A1TSHR
SCHEMBL27753904 0.77 CA1 (0.61) SMN1; SMN2NFE2L2MAPK1ALDH1A1TSHR
SCHEMBL151213 0.77 CA1 (0.61) SMN1; SMN2NFE2L2MAPK1ALDH1A1TSHR
SCHEMBL12129060 0.76 SMN1; SMN2 (0.57) SMN1; SMN2MAPK1ABCB1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0675895-B1 ETOPOSIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS A DRUG AND IN THE PREPARATION OF A DRUG FOR TREATING CANCER PF MEDICAMENT (FR) 1997-07-23 EP claimed
US-5643885-A Etoposide derivatives, process for preparing them, their use as a medicinal product and their use for the preparation of a medicinal product intended for anti-cancer treatment PIERRE FABRE MEDICAMENT (FR) 1997-07-01 US claimed
JP-H08504795-A 1996-05-21 JP claimed
EP-0675895-A1 ETOPOSIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS A DRUG AND IN THE PREPARATION OF A DRUG FOR TREATING CANCER. FABRE PIERRE COSMETIQUE (FR) 1995-10-11 EP claimed
WO-1994014829-A1 ETOPOSIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS A DRUG AND IN THE PREPARATION OF A DRUG FOR TREATING CANCER PIERRE FABRE MEDICAMENT (FR) 1994-07-07 WO claimed
EP-0675895-B1 ETOPOSIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS A DRUG AND IN THE PREPARATION OF A DRUG FOR TREATING CANCER PF MEDICAMENT (FR) 1997-07-23 EP disclosed
US-5643885-A Etoposide derivatives, process for preparing them, their use as a medicinal product and their use for the preparation of a medicinal product intended for anti-cancer treatment PIERRE FABRE MEDICAMENT (FR) 1997-07-01 US disclosed